Chamutal Gur

机构：Hebrew University of Jerusalem, Hadassah Medical Center, Concern Foundation, Weizmann Institute of Science · ORCID：0000-0001-5191-2956

发表论文 132 篇 · 总被引 5411 次 · h-index 30

代表论文

• ZEB2 is a master switch controlling the tumor-associated macrophage program (2025 · Cancer Cell · 被引 40)
• Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols (2024 · Nature Cancer · 被引 30)
• Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy (2025 · Cell · 被引 25)
• Dissection of the immune landscape in psoriatic arthritis defines immunoproteasome up-regulation in treatment resistance (2025 · Science Immunology · 被引 6)
• Localized PD-1 CAR T therapy reprograms neuroinflammation (2026 · Cell · 被引 1)
• BCMA-targeted CAR T-cell therapy in refractory autoimmune diseases: Initial Results from a Phase 1 clinical trial (2025 · Blood · 被引 1)